Sanders Capital
GILD icon

Sanders Capital’s Gilead Sciences GILD Stock Holding History

Sanders Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-11,392,884
Closed -$740M – 41
2019
Q4 		$740M Buy
11,392,884
+194,791
+2% +$12.7M 2.62% 17
2019
Q3 		$710M Sell
11,198,093
-327,940
-3% -$21.4M 3.19% 14
2019
Q2 		$779M Buy
11,526,033
+234,100
+2% +$15.4M 3.58% 11
2019
Q1 		$734M Buy
11,291,933
+539,793
+5% +$35.9M 3.52% 10
2018
Q4 		$673M Buy
10,752,140
+236,540
+2% +$16.5M 3.74% 11
2018
Q3 		$812M Sell
10,515,600
-63,975
-0.6% -$4.83M 4.09% 7
2018
Q2 		$749M Buy
10,579,575
+696,200
+7% +$49.2M 4.02% 7
2018
Q1 		$745M Sell
9,883,375
-27,118
-0.3% -$2.16M 4.13% 7
2017
Q4 		$710M Buy
9,910,493
+5,026,015
+103% +$382M 3.86% 11
2017
Q3 		$396M Buy
+4,884,478
New +$374M 2.39% 18

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Sanders Capital's GILD Position: Q1 2020 in Review

Sanders Capital sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 11,392,884 shares — an estimated $740M sold.

Sanders Capital first reported a position in GILD in Q3 2017 and held it in 10 quarters. The position peaked at $812M in Q3 2018. 1,644 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • Sanders Capital reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
  • Sanders Capital sold 11,392,884 Gilead Sciences shares in Q1 2020, an estimated $740M.
  • Sanders Capital first reported a position in Gilead Sciences in Q3 2017 and held it in 10 quarters.
  • Sanders Capital's Gilead Sciences position peaked at $812M in Q3 2018.
  • 1,644 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on Sanders Capital's 13F filing for Q1 2020, filed 28 May 2020.